FindTrial
Sign In

Clinical features of implantable cardiac device infection and outcomes after lead extraction

Clinical features of implantable cardiac device infection and outcomes after lead extraction

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INC-16009615
Enrollment
Unknown
Registered
2016-10-26
Start date
2017-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cardiac device infection

Interventions

lead extraction group:lead extraction

Sponsors

Shanghai Sixth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients who correspond to implant standards of CIED, such as pacemaker, ICD or CRT; 2. Patients who was diagnosed as pacemaker pocket infection (such as abscess, diabrosis, bare CIED), bloodstream infection (bacteremia) and infective endocarditis (valve or lead involvement); 3. Aged 18 years and elder; 4. Be willing to sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Life expectancy is less than 1 year of end-stage diseases; 2. Patients who rufuse to remove CIED system; 3. Pregnancy or lactation; 4. Other conditions determined by researchers should be excluded.

Design outcomes

Primary

MeasureTime frame
postoperative complications;—

Secondary

MeasureTime frame
microorganism culture;UCG;—

Countries

China

Contacts

Public ContactJingbo Li

Shanghai Sixth People's Hospital

lijb@sjtu.edu.cn+86 18930177515

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026